The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated•Originally published 13 April 2026•Updated 14 April 2026•

1 min read

GE HealthCare and Medtronic Partner to Advance Neurosurgical Imaging Technology

Jensen Huang and Mark Zuckerberg stand in front of server racks with Nvidia and Meta logos, AI text, and glowing circuit patterns.

Key Facts

1GE HealthCare integrated its bkActiv imaging system with Medtronic's Stealth AXiS platform.

about 2 months ago

Version History

Version 1about 2 months ago

What changed: The story was updated to include FDA clearance for the integrated system, its focus on addressing 'brain shift', and the scheduled showcase in May 2026.

GE HealthCare and Medtronic have received FDA clearance for their integrated imaging and navigation system designed for cranial procedures. The solution combines the bkActiv ultrasound system with Medtronic’s Stealth AXiS guidance technology to provide neurosurgeons with high-resolution, real-time visualization. This technology specifically addresses the clinical challenge of 'brain shift' during surgery, enhancing precision and potentially reducing risks during delicate interventions. By unifying these platforms, the companies aim to streamline clinical workflows and improve decision-making through live data delivery within the navigation environment. The integrated system is scheduled to be showcased at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2026. This milestone strengthens the competitive position of both GEHC and MDT in the global medtech market.